Tris Pharma Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2033 Route 130 South Suite D, Monmouth Junction, New Jersey (NJ) 08852, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3004712471 · DUNS 947472119
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-11-21
- VAIBioresearch Monitoring2024-03-08
- VAIDrug Quality Assurance2021-06-08
- OAIDrug Quality Assurance2019-01-23
- VAIBioresearch Monitoring2018-04-16
- OAIDrug Quality Assurance2017-03-20
- NAIDrug Quality Assurance2016-01-27
- VAIBioresearch Monitoring2015-08-12
- VAIDrug Quality Assurance2014-10-01
- VAIDrug Quality Assurance2014-01-21
- VAIDrug Quality Assurance2012-06-15
- VAIDrug Quality Assurance2011-05-06
- NAIDrug Quality Assurance2010-04-30
- NAIDrug Quality Assurance2009-11-03
Drugs this plant is listed as making
5 distinct drugs across 10 products name this site in their FDA label.
- amphetamineNextWave Pharmaceuticals, Inc
- Carbinoxamine MaleateNeos Therapeutics, LP
- Dextroamphetamine SulfateCranbury Pharmaceuticals, LLC
- Promethazine Hydrochloride and Codeine PhosphateCosette Pharmaceuticals, Inc.
- RisperidoneCranbury Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.